|
| |
|
|
| |
|
|
2008 iBio
(May 18-22, 2008,Hangzhou,China)
|
|
|
|
|
|
|
|
|
|
|
|
|
CEMD-2008
(
Oct.22-28, 2008, Beijing & Xi'an, China )
|
|
|
WCV 2008
( Dec.1-5, 2008, Guangzhou, China) |
|
|
|
|
|
|
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China)
|
|
|
|
|
|
| |
|
|
|
|
|
| |
| Track 4: Therapeutics Development for Diseases |
| -Delivering Promises for Future Drugs |
| |
| Section 4-1: Drug Discovery and Development against Major Diseases |
| Session 36: Anti-Emerging Disease Drug Discovery and Development |
| Session 37: Cancer Therapeutics Discovery and Development |
| Session 38: CNS Disorder Drug Discovery and Development |
| Session 39: Anti-HIV Drug Discovery and Development |
| Session 40: Anti-HCV Drug Discovery and Development |
| Session 41: HPV and Other Antiviral Drug Discovery and Development |
| Session 42: Antifungal Drug Discovery and Development |
| Session 43: Cardiovascular Drug Discovery and Development |
| Session 44: Neurodegenerative Diseases Drug Discovery and Development |
| Session 45: Metabolic Diseases Drug Discovery and Development |
| Session 46: Asthma/COPD Drug Discovery and Development |
| Session 47: Autoimmune Disorder Drug Discovery and Development |
| Session 48: Anti-Allergy Drug Discovery and Development |
| Session 49: MDR Drug Resistant Bacterial/Parasite Infections, TB and Malaria |
| Session 50: Drug Discovery and Development against Severe Gastrointestinal Disorders |
| Section 4-2: Novel Biopharmaceutical Drug Discovery and Development |
| Session 51: Novel Regenerative Medicine Therapeutics and Stem Cell Therapies |
| Session 52: Alternative Cell Therapeutics Discovery and Development |
| Session 53: Therapeutic Monoclonal Antibody Development |
| Session 54: New Preventive and Therapeutic Vaccine Discovery and Development |
| Session 55: Gene Therapeutics/Nucleic Acid Based Drug Discovery and Development |
|
| |
| |
| |
| |
| |
|
|